Main description:

Many psychotropic drugs are used to treat childhood and adolescent mental illness on the basis of efficacy in adults, despite not being currently approved for use in the young. The lack of approval does not necessarily reflect lack of safety or efficacy, but it does reflect a lack of controlled studies. The Clinical Handbook of Psychotropic Drugs for Children & Adolescents is a unique resource to help you make the right choice for younger patients: Independent, unbiased, evidence-based, clinically relevant Based on independent published literature, including randomized controlled trials, open and double-blind studies, pharmacokinetic trials, cohort trials, case series, and case reports, as well as the experience of leading clinical experts Includes monograph statements regarding use of each drug in children and adolescents Shows approved and nonapproved indications for children and adolescents, as well as for adults Dosage comparisons based on scientific data Unique comparison charts, handouts for patients/caregivers, and much more

Contents:

Table of Contents Psychiatric Disorders in Children and Adolescents Attention-Deficit/Hyperactivity Disorder (ADHD) Major Depressive Disorder (MDD) Disruptive Mood Dysregulation Disorder (DMDD) Bipolar Disorder (BD) Schizophrenia ANXIETY DISORDERS Separation Anxiety Disorder Generalized Anxiety Disorder (GAD) Social Anxiety Disorder Panic Disorder Specific Phobia Obsessive-Compulsive Disorder (OCD) TRAUMA- AND STRESSOR-RELATED DISORDERS Posttraumatic Stress Disorder (PTSD) TIC DISORDERS Tourette's Disorder Autism Spectrum Disorder (ASD) DISRUPTIVE, IMPULSE-CONTROL, AND CONDUCT DISORDERS Conduct Disorder (CD) Oppositional Defiant Disorder (ODD) Drugs for ADHD Psychostimulants Atomoxetine Comparison of Drugs for ADHD alpha2 Agonists Augmentation Strategies in ADHD Antidepressants Selective Serotonin Reuptake Inhibitors (SSRI) Norepinephrine Dopamine Reuptake Inhibitor (NDRI) Serotonin Norepinephrine Reuptake Inhibitor (SNRI) Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) Serotonin-1A Agonist/Serotonin Reuptake Inhibitor Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) Nonselective Cyclic Antidepressants Monoamine Oxidase Inhibitors Reversible Inhibitor of MAO-A (RIMA) Irreversible Monoamine Oxidase (A&B) Inhibitors (MAOIs) Effects of Antidepressants on Neurotransmitters/Receptors Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses Antidepressant Doses and Pharmacokinetics Switching Antidepressants Antidepressant Augmentation Strategies Electroconvulsive Therapy (ECT) Antipsychotics "Second-Generation" Antipsychotics/SGAs "Third-Generation" Antipsychotic/TGA "First-Generation" Antipsychotics/FGAs Effects of Antipsychotics on Neurotransmitters/Receptors Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptors Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses Antipsychotic Doses and Pharmacokinetics (Oral and Short- Acting Injections) Comparison of Long-Acting IM Antipsychotics Switching Antipsychotics Antipsychotic Augmentation Strategies Antipsychotic-Induced Extrapyramidal Side Effects (EPSE) and Their Management Extrapyramidal Side Effects of Antipsychotics Treatment Options for Extrapyramidal Side Effects Effects on Extrapyramidal Symptoms Comparison of Agents for Treating Acute Extrapyramidal Side Effects Doses and Pharmacokinetics of Agents for Treating Acute Extrapyramidal Side Effects Anxiolytic (Antianxiety) Agents Benzodiazepines Comparison of the Benzodiazepines Buspirone Hypnotics/Sedatives Comparison of Hypnotics/Sedatives Mood Stabilizers Lithium Anticonvulsants Comparison of Anticonvulsants Frequency of Adverse Reactions to Mood Stabilizers at Therapeutic Doses Drugs/Substances of Abuse Alcohol Stimulants Hallucinogens Opioids Inhalants/Aerosols Sodium Oxybate (Gamma-Hydroxybutyrate - GHB) Flunitrazepam (Rohypnol) Nicotine/Tobacco Treatment of Substance Use Disorders Disulfiram Acamprosate Naltrexone Methadone Buprenorphine Pharmacotherapy for Nicotine/Tobacco Use Dependence Unapproved Treatments of Psychiatric Disorders Adrenergic Agents Cholinergic Agents Dopaminergic Agents GABA Agents/Anticonvulsants Miscellaneous NMDA Agents Natural Health Products Glossary Drug Use in Pregnancy and Effects on Breast Milk Patient and Caregiver Information Sheets Index of Drugs